Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro

OBJECTIVE: Dendritic cells (DCs) are administered as immunotherapeutic adjuvants after the completion of standard treatment in most settings. However, our Phase I trial indicated that one patient out of four, who received autologous tumor lysate-pulsed dendritic cell (TLDC) also received cisplatin c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Gynecol Oncol
Hoofdauteurs: Dhandapani, Hemavathi, Seetharaman, Abirami, Jayakumar, Hascitha, Ganeshrajah, Selvaluxmy, Singh, Shirley Sunder, Thangarajan, Rajkumar, Ramanathan, Priya
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8192235/
https://ncbi.nlm.nih.gov/pubmed/33908712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e59
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items